These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 11827434

  • 1. Benfotiamine is similar to thiamine in correcting endothelial cell defects induced by high glucose.
    Pomero F, Molinar Min A, La Selva M, Allione A, Molinatti GM, Porta M.
    Acta Diabetol; 2001; 38(3):135-8. PubMed ID: 11827434
    [Abstract] [Full Text] [Related]

  • 2. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions.
    La Selva M, Beltramo E, Pagnozzi F, Bena E, Molinatti PA, Molinatti GM, Porta M.
    Diabetologia; 1996 Nov; 39(11):1263-8. PubMed ID: 8932990
    [Abstract] [Full Text] [Related]

  • 3. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose.
    Beltramo E, Berrone E, Buttiglieri S, Porta M.
    Diabetes Metab Res Rev; 2004 Nov; 20(4):330-6. PubMed ID: 15250036
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Benfotiamine prevents macro- and microvascular endothelial dysfunction and oxidative stress following a meal rich in advanced glycation end products in individuals with type 2 diabetes.
    Stirban A, Negrean M, Stratmann B, Gawlowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribarri J, Vlassara H, Tschoepe D.
    Diabetes Care; 2006 Sep; 29(9):2064-71. PubMed ID: 16936154
    [Abstract] [Full Text] [Related]

  • 6. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose.
    Berrone E, Beltramo E, Solimine C, Ape AU, Porta M.
    J Biol Chem; 2006 Apr 07; 281(14):9307-13. PubMed ID: 16452468
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats.
    Stracke H, Hammes HP, Werkmann D, Mavrakis K, Bitsch I, Netzel M, Geyer J, Köpcke W, Sauerland C, Bretzel RG, Federlin KF.
    Exp Clin Endocrinol Diabetes; 2001 Apr 07; 109(6):330-6. PubMed ID: 11571671
    [Abstract] [Full Text] [Related]

  • 8. The multifaceted therapeutic potential of benfotiamine.
    Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A.
    Pharmacol Res; 2010 Jun 07; 61(6):482-8. PubMed ID: 20188835
    [Abstract] [Full Text] [Related]

  • 9. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.
    Beltramo E, Berrone E, Tarallo S, Porta M.
    Acta Diabetol; 2008 Sep 07; 45(3):131-41. PubMed ID: 18581039
    [Abstract] [Full Text] [Related]

  • 10. Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine.
    Beltramo E, Berrone E, Tarallo S, Porta M.
    Diabetes Metab Res Rev; 2009 Sep 07; 25(6):566-76. PubMed ID: 19593734
    [Abstract] [Full Text] [Related]

  • 11. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.
    Gadau S, Emanueli C, Van Linthout S, Graiani G, Todaro M, Meloni M, Campesi I, Invernici G, Spillmann F, Ward K, Madeddu P.
    Diabetologia; 2006 Feb 07; 49(2):405-20. PubMed ID: 16416271
    [Abstract] [Full Text] [Related]

  • 12. Benfotiamine exhibits direct antioxidative capacity and prevents induction of DNA damage in vitro.
    Schmid U, Stopper H, Heidland A, Schupp N.
    Diabetes Metab Res Rev; 2008 Feb 07; 24(5):371-7. PubMed ID: 18384109
    [Abstract] [Full Text] [Related]

  • 13. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.
    Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ.
    Diabetes; 2003 Aug 07; 52(8):2110-20. PubMed ID: 12882930
    [Abstract] [Full Text] [Related]

  • 14. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy.
    Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M.
    Nat Med; 2003 Mar 07; 9(3):294-9. PubMed ID: 12592403
    [Abstract] [Full Text] [Related]

  • 15. Benfotiamine alleviates diabetes-induced cerebral oxidative damage independent of advanced glycation end-product, tissue factor and TNF-alpha.
    Wu S, Ren J.
    Neurosci Lett; 2006 Feb 13; 394(2):158-62. PubMed ID: 16260089
    [Abstract] [Full Text] [Related]

  • 16. Human pericyte-endothelial cell interactions in co-culture models mimicking the diabetic retinal microvascular environment.
    Tarallo S, Beltramo E, Berrone E, Porta M.
    Acta Diabetol; 2012 Dec 13; 49 Suppl 1():S141-51. PubMed ID: 22527094
    [Abstract] [Full Text] [Related]

  • 17. PP2A contributes to endothelial death in high glucose: inhibition by benfotiamine.
    Du Y, Kowluru A, Kern TS.
    Am J Physiol Regul Integr Comp Physiol; 2010 Dec 13; 299(6):R1610-7. PubMed ID: 20881100
    [Abstract] [Full Text] [Related]

  • 18. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Verma S, Reddy K, Balakumar P.
    Biol Trace Elem Res; 2010 Oct 13; 137(1):96-109. PubMed ID: 19943121
    [Abstract] [Full Text] [Related]

  • 19. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling.
    Marchetti V, Menghini R, Rizza S, Vivanti A, Feccia T, Lauro D, Fukamizu A, Lauro R, Federici M.
    Diabetes; 2006 Aug 13; 55(8):2231-7. PubMed ID: 16873685
    [Abstract] [Full Text] [Related]

  • 20. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.
    Volvert ML, Seyen S, Piette M, Evrard B, Gangolf M, Plumier JC, Bettendorff L.
    BMC Pharmacol; 2008 Jun 12; 8():10. PubMed ID: 18549472
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.